Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature
- PMID: 20803209
- DOI: 10.1007/s00404-010-1653-4
Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature
Abstract
Introduction: Extra-mammary Paget disease is one of the rare neoplastic conditions of the skin. The most common site of involvement is the vulva and presents itself with erythematous plaques. Surgery is the most important treatment option. In the recent years, there are publications of the topical use of imiquimod cream in extra-mammary cutaneous Paget disease. We report the case of a woman with recurrent vulvar Paget disease, who underwent successful treatment with imiquimod cream. We also review the reports of other patients with vulvar Paget disease who were treated with topical imiquimod cream.
Case report: A 65-year-old woman presented to the Oncology Outpatient Clinic with an itchy lesion in her vulva for 2 years. In the gynecologic examination, a hyperkeratotic erythematous lesion was found starting from the right labium to involve clitoris, with a size of 4 × 3 cm. Pathology result was reported as Paget disease. She was operated and wide vulvar excision was performed with a safety margin of 2 cm. Then recurrence two times occurred. Because she refused surgery, imiquimod cream 5% was applied for treatment.
Conclusion: Imiquimod cream is an effective and safe therapeutic agent for both primary and recurring vulvar Paget disease.
Similar articles
-
Conservative management of extramammary paget disease with imiquimod.J Low Genit Tract Dis. 2012 Jan;16(1):59-63. doi: 10.1097/LGT.0b013e31822d2484. J Low Genit Tract Dis. 2012. PMID: 21964211
-
Treatment of primary vulvar paget disease with 5% imiquimod cream.J Low Genit Tract Dis. 2014 Oct;18(4):347-50. doi: 10.1097/LGT.0000000000000053. J Low Genit Tract Dis. 2014. PMID: 25259595
-
The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease.Am J Obstet Gynecol. 2022 Aug;227(2):250.e1-250.e8. doi: 10.1016/j.ajog.2022.04.012. Epub 2022 Apr 18. Am J Obstet Gynecol. 2022. PMID: 35447145
-
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].Gynakol Geburtshilfliche Rundsch. 2009;49(4):326-30. doi: 10.1159/000301110. Epub 2010 May 19. Gynakol Geburtshilfliche Rundsch. 2009. PMID: 20530949 Review. German.
-
Treatment of extramammary Paget disease with topical imiquimod cream: case report and literature review.South Med J. 2006 Apr;99(4):396-402. doi: 10.1097/01.smj.0000209223.68763.b1. South Med J. 2006. PMID: 16634252 Review.
Cited by
-
Multiple concurrent primary extramammary Paget's disease.Malays Fam Physician. 2016 Apr 30;11(1):18-21. eCollection 2016. Malays Fam Physician. 2016. PMID: 28461844 Free PMC article.
-
Axillary Paget disease with a visible satellite: a case report and literature review.Diagn Pathol. 2021 Aug 1;16(1):69. doi: 10.1186/s13000-021-01131-1. Diagn Pathol. 2021. PMID: 34334143 Free PMC article. Review.
-
Interventions for the treatment of Paget's disease of the vulva.Cochrane Database Syst Rev. 2019 Jun 5;6(6):CD009245. doi: 10.1002/14651858.CD009245.pub3. Cochrane Database Syst Rev. 2019. PMID: 31167037 Free PMC article.
-
HDR-plesiotherapy for the treatment of anogenital extramammary Paget's disease.Rep Pract Oncol Radiother. 2012 May 3;17(3):163-7. doi: 10.1016/j.rpor.2012.03.006. eCollection 2012. Rep Pract Oncol Radiother. 2012. PMID: 24377019 Free PMC article.
-
Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients.Cancer Immunol Immunother. 2024 Oct 3;73(12):252. doi: 10.1007/s00262-024-03846-8. Cancer Immunol Immunother. 2024. PMID: 39358617 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical